Related Experiment Video
Updated: Jul 16, 2026

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
Published on: October 6, 2014
SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion
Takanori Kitamura1, Kohei Kometani, Hiroki Hashida
1Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Abstract:
Inactivation of TGF-beta family signaling is implicated in colorectal tumor progression. Using cis-Apc(+/Delta716) Smad4(+/-) mutant mice (referred to as cis-Apc/Smad4), a model of invasive colorectal cancer in which TGF-beta family signaling is blocked, we show here that a new type of immature myeloid cell (iMC) is recruited from the bone marrow to the tumor invasion front. These CD34(+) iMCs express the matrix metalloproteinases MMP9 and MMP2 and the CC-chemokine receptor 1 (CCR1) and migrate toward the CCR1 ligand CCL9. In adenocarcinomas, expression of CCL9 is increased in the tumor epithelium. By deleting Ccr1 in the background of the cis-Apc/Smad4 mutant, we further show that lack of CCR1 prevents accumulation of CD34(+) iMCs at the invasion front and suppresses tumor invasion. These results indicate that loss of transforming growth factor-beta family signaling in tumor epithelium causes accumulation of iMCs that promote tumor invasion.
Insights
Loss of TGF-beta signaling in colorectal cancer recruits immature myeloid cells (iMCs) that promote invasion. Blocking CCR1 signaling prevents iMC accumulation and suppresses tumor spread.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Transforming growth factor-beta (TGF-beta) signaling is crucial in tumor suppression.
- Inactivation of TGF-beta signaling is linked to colorectal cancer progression.
Purpose of the Study:
- To investigate the role of immature myeloid cells (iMCs) in colorectal tumor invasion.
- To elucidate the mechanism by which TGF-beta pathway inactivation promotes tumor spread.
Main Methods:
- Utilized cis-Apc(+/Delta716) Smad4(+/-) mutant mice, a model for invasive colorectal cancer with blocked TGF-beta signaling.
- Analyzed the recruitment and characteristics of iMCs at the tumor invasion front.
- Investigated the role of CC-chemokine receptor 1 (CCR1) and its ligand CCL9 in iMC migration and tumor invasion using gene deletion models.
Main Results:
- Identified a novel population of CD34(+) iMCs recruited from bone marrow to the tumor invasion front.
- These iMCs express matrix metalloproteinases (MMP9, MMP2) and CCR1, migrating towards CCL9.
- CCL9 expression was elevated in tumor epithelium of adenocarcinomas.
- Deleting Ccr1 abolished iMC accumulation and significantly suppressed tumor invasion.
Conclusions:
- Loss of TGF-beta signaling in colorectal tumors drives the recruitment of iMCs.
- The CCR1-CCL9 axis mediates iMC accumulation and promotes tumor invasion.
- Targeting iMC recruitment via CCR1 inhibition represents a potential therapeutic strategy for colorectal cancer.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

